Literature DB >> 2975671

Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).

H W Ziegler-Heitbrock1, D Stachel, T Schlunk, L Gürtler, W Schramm, M Fröschl, J R Bogner, G Riethmüller.   

Abstract

In a selected group of human immunodeficiency virus (HIV)-infected patients we confirm the expansion of a CD8+ T-lymphocyte subset, i.e., the CD8+/Leu7+ cells, which account for 30% of the lymphocytes, compared to 3% in the control donors. In addition, a CD8+ T-lymphocyte subset that coexpresses class II (DR) antigens, i.e., CD8+/DR+ cells, is also increased from 1.5% in controls to 27% in the HIV-infected patients. Using three-color immunofluorescence and flow cytometry we can demonstrate that the CD8+/Leu7+ and the CD8+/class II+ cells are not distinct but overlapping subsets. In the HIV-infected patients 42% of the CD8+/Leu7+ cells were strongly positive for class II and these CD8+/Leu7+/class II+ cells accounted for 13% of all lymphocytes. These findings indicate that the expanded CD8+/Leu7+ cells are activated and hence might be actively involved in immune defense in acquired immune deficiency syndrome (AIDS).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975671     DOI: 10.1007/bf00916953

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  15 in total

1.  Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome.

Authors:  D E Lewis; J M Puck; G F Babcock; R R Rich
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

2.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.

Authors:  E Leroy; C F Calvo; M Divine; M F Gourdin; F Baujean; M H Ben Aribia; Z Mishal; J P Vernant; J P Farcet; A Senik
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Effects of herpes virus carrier status on peripheral T lymphocyte subsets.

Authors:  J W Gratama; A M Naipal; M A Oosterveer; T Stijnen; H C Kluin-Nelemans; L A Ginsel; G J den Ottolander; A C Hekker; J D'Amaro; M van der Giessen
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

5.  T-cytotoxic/suppressor cell phenotypes in a group of asymptomatic homosexual men with and without exposure to HTLV-III/LAV.

Authors:  J K Nicholson; D F Echenberg; B M Jones; H W Jaffe; P M Feorino; J S McDougal
Journal:  Clin Immunol Immunopathol       Date:  1986-09

6.  Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS).

Authors:  S Plaeger-Marshall; C A Spina; J V Giorgi; R Mitsuyasu; P Wolfe; M Gottlieb; G Beall
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

7.  Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.

Authors:  D P Stites; C H Casavant; T M McHugh; A R Moss; S L Beal; J L Ziegler; A M Saunders; N L Warner
Journal:  Clin Immunol Immunopathol       Date:  1986-02

8.  Correlation of natural killer cell function with Leu 7 reactivity in patients with humoral immunodeficiency.

Authors:  T Huwyler; A Morell; A Hirt; C Ricci; H P Wagner; S Barandun
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Distinctive lymphocyte subpopulation abnormalities in patients with congenital coagulation disorders who exhibit lymph node enlargement.

Authors:  H E Prince; J K Kreiss; C K Kasper; S Kleinman; A M Saunders; L Waldbeser; G Mandigo; H S Kaplan
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

10.  Expansion of a minor subpopulation of peripheral blood lymphocytes (T8+/Leu 7+) in patients with haemophilia.

Authors:  H W Ziegler-Heitbrock; W Schramm; D Stachel; H Rumpold; D Kraft; D Wernicke; K von der Helm; J Eberle; F Deinhardt; E P Rieber
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

View more
  11 in total

Review 1.  Lymphocyte subsets as surrogate markers in antiretroviral therapy.

Authors:  J R Bogner; F D Goebel
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children.

Authors:  M C Aldhous; G M Raab; K V Doherty; J Y Mok; A G Bird; K S Froebel
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

3.  T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.

Authors:  M Levacher; S Tallet; M C Dazza; E Dournon; B Rouveix; J J Pocidalo
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes.

Authors:  N Tedla; J Dwyer; P Truskett; D Taub; D Wakefield; A Lloyd
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus.

Authors:  K A Reimann; G B Snyder; L V Chalifoux; B C Waite; M D Miller; H Yamamoto; O Spertini; N L Letvin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

6.  Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

Authors:  M C Aldhous; K C Watret; J Y Mok; A G Bird; K S Froebel
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.

Authors:  K C Watret; J A Whitelaw; K S Froebel; A G Bird
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  T cell activation and disease severity in HIV infection.

Authors:  M Mahalingam; M Peakman; E T Davies; A Pozniak; T J McManus; D Vergani
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

10.  Expansion of activated T lymphocytes (CD3 + HLA/DR +) detectable in early stages of HIV-1 infection.

Authors:  J R Bogner; A Matuschke; B Heinrich; M A Schreiber; C Nerl; F D Goebel
Journal:  Klin Wochenschr       Date:  1990-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.